TokenPost topic
1 TokenPost story is tagged HUNT1. The newest appear first.
The company reported $45.2 million in cash, cash equivalents and marketable securities. HUNT1 is an enrolling Phase Ib/IIa program for Huntington’s disease.
Nov 13, 2026, 1:38 AM EST · Business
